Abstract
The number of protein based pharmaceuticals reaching the marketplace has
exponentially increased over the past few years. As the global demand for
innovative protein therapeutics is growing each year, a large number of
investors are pouring money in the market. Moreover, new developments in
manufacturing & production technology have led to significant advancements in
protein manufacturing and production. The global protein therapeutics market
registered a robust growth rate of over 14% in 2008.
According to our new research report “Global Protein Therapeutics Market
Analysis”, the global protein therapeutics market is expected to grow at
a CAGR of around 12% during 2010-2012. At present, the market is characterized
by high cost treatments therapy and healthcare insurance which in turn helping
the companies to generate more revenue.
Our report has found that the market is presently dominated by Monoclonal
Antibodies. With double-digit growth projected for future, the segment is
expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and
coagulation factors are also exhibiting healthy growth rates. One of the
biggest opportunity areas in the protein therapeutics market is biogenerics
which are expected to create a multi-billion dollar market in future.
Moreover, pharmaceutical contract research and manufacturing market is
expected to grow at an unmatched rate on account of high cost factor in the
market.
This report provides extensive information and rational analysis of the global
protein therapeutics market. It includes detailed study of factors fueling
growth in the protein therapeutics market to help clients gain deeper insight
of the current and future trends in the global protein therapeutics market.
The report also provides segment-wise market trends prevailing at regional
level to provide an overview of developments taking place in these segments
across the world.
| 
View Cart
